Table 1.

Reports on SN mapping for gastric cancer

Ref.	Year	Journal	n	Detection rate	Sensitivity
RI method
Kitagawa et al[31]	2000	Surg Clin N Am	36	97%	100%
Kitagawa et al[8]	2002	Br J Surg	145	95%	92%
Gretschel et al[32]	2003	Chirurg	15	93%	89%
Kim MC et al[33]	2004	Ann Surg	46	93.50%	84.60%
Uenosono et al[34]	2005	Br J Surg	104	95.20%	81.80%
Arigami et al[30]	2006	Ann Surg	61	100%	95.50%
Mochiki et al[35]	2006	Am J Surg	59	96.60%	83.30%
Yanagita et al[36]	2008	Ann Surg Oncol	160	98.80%	96.70%
Mean			63.2	96%	90%
Dye method
Hiratsuka et al[7]	2001	Surgery	77	99%	90%
Ichikura et al[37]	2002	World J Surg	62	100%	85%
Carlini et al[38]	2002	J Exp Clin Cancer Res	40	100%	87%
Miwa et al[9]	2003	Br J Surg	211	96%	89%
Ryu et al[39]	2003	Eur J Surg Oncol	71	92%	100%
Song et al[40]	2004	Am J Surg	27	96%	100%
Osaka et al[41]	2004	Clin Cancer Res	57	100%	100%
Ishizaki et al[42]	2006	Eur J Surg Oncol	62	85.70%	96.40%
Park et al[43]	2006	Eur J Surg Oncol	100	94.60%	78.60%
Rino et al[44]	2007	Hepatogastroenterology	43	93.00%	81.80%
Mean			70.2	96%	91%
RI + Dye mthod
Hayashi et al[45]	2003	J Am Coll Surg	31	100%	100%
Karube et al[46]	2004	J Surg Oncol	41	100%	92%
Tonouchi et al[47]	2005	World J Surg	37	94.60%	100%
Gretschel et al[48]	2005	Eur J Surg Oncol	34	97.10%	95.40%
Ichikura et al[49]	2006	Surgery	80	100%	92.90%
Saikawa et al[50]	2006	World J Surg	35	94.30%	50%
Dye + IREE method
Nimura et al[10]	2004	Br J Surg	84	99%	100%
Ohdaira et al[11]	2007	Gastric Cancer	60	100%	100%
Kelder et al[12]	2010	Eur J Surg Oncol	212	99.50%	97%
Mean				100%	99%
Dye + Fluorcence method
Miyashiro et al[22]	2008	Ann Surg Oncol	3	100%	100%
Kusano et al[23]	2008	Dig Surg	22	90.10%	40.00%
Tajima et al[51]	2009	Ann Surg	56	96.40%	64.70%
Mean				96%	68%